Torii Pharmaceutical Future Growth
Future criteria checks 0/6
Torii Pharmaceutical's earnings are forecast to decline at 1% per annum while its annual revenue is expected to grow at 3.9% per year. EPS is expected to decline by 1% per annum. Return on equity is forecast to be 4.4% in 3 years.
Key information
-1.0%
Earnings growth rate
-1.0%
EPS growth rate
| Pharmaceuticals earnings growth | 11.7% |
| Revenue growth rate | 3.9% |
| Future return on equity | 4.4% |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 72,300 | 6,855 | 5,615 | N/A | 2 |
| 12/31/2025 | 66,450 | 5,915 | 3,958 | N/A | 2 |
| 12/31/2024 | 60,925 | 4,970 | 695 | N/A | 2 |
| 9/30/2024 | 58,839 | 5,276 | N/A | N/A | N/A |
| 6/30/2024 | 57,248 | 5,254 | 1,089 | 1,256 | N/A |
| 3/31/2024 | 56,278 | 5,285 | N/A | N/A | N/A |
| 12/31/2023 | 54,638 | 4,119 | -3,339 | -3,123 | N/A |
| 9/30/2023 | 52,713 | 3,456 | N/A | N/A | N/A |
| 6/30/2023 | 51,493 | 3,185 | 81 | 265 | N/A |
| 3/31/2023 | 49,747 | 2,774 | N/A | N/A | N/A |
| 12/31/2022 | 48,896 | 3,944 | 2,139 | 2,420 | N/A |
| 9/30/2022 | 48,865 | 3,992 | N/A | N/A | N/A |
| 6/30/2022 | 48,534 | 3,975 | 2,066 | 2,424 | N/A |
| 3/31/2022 | 48,048 | 3,820 | N/A | N/A | N/A |
| 12/31/2021 | 46,987 | 3,374 | -530 | -156 | N/A |
| 9/30/2021 | 44,965 | 3,225 | N/A | N/A | N/A |
| 6/30/2021 | 43,398 | 2,939 | -226 | 266 | N/A |
| 3/31/2021 | 42,028 | 3,069 | N/A | N/A | N/A |
| 12/31/2020 | 41,700 | 3,495 | -3,854 | -3,443 | N/A |
| 9/30/2020 | 41,850 | 3,409 | N/A | N/A | N/A |
| 6/30/2020 | 42,171 | 2,973 | -12,178 | -11,961 | N/A |
| 3/31/2020 | 43,408 | -293 | N/A | N/A | N/A |
| 12/31/2019 | 42,998 | 27,367 | 42,080 | 42,499 | N/A |
| 9/30/2019 | 48,328 | 25,382 | N/A | N/A | N/A |
| 6/30/2019 | 52,684 | 25,810 | 53,432 | 54,047 | N/A |
| 3/31/2019 | 57,782 | 29,117 | N/A | N/A | N/A |
| 12/31/2018 | 62,551 | 1,164 | 7,731 | 8,259 | N/A |
| 9/30/2018 | 63,952 | 4,195 | N/A | N/A | N/A |
| 6/30/2018 | 64,596 | 4,505 | N/A | 7,124 | N/A |
| 3/31/2018 | 64,457 | 4,899 | N/A | N/A | N/A |
| 12/31/2017 | 64,135 | 4,718 | N/A | 6,349 | N/A |
| 9/30/2017 | 62,164 | 3,855 | N/A | N/A | N/A |
| 6/30/2017 | 61,283 | 3,117 | N/A | 4,699 | N/A |
| 3/31/2017 | 60,074 | 2,424 | N/A | N/A | N/A |
| 12/31/2016 | 60,206 | 2,839 | N/A | 3,402 | N/A |
| 9/30/2016 | 61,305 | 2,951 | N/A | N/A | N/A |
| 6/30/2016 | 61,957 | 3,378 | N/A | 3,136 | N/A |
| 3/31/2016 | 62,820 | 3,798 | N/A | N/A | N/A |
| 12/31/2015 | 62,378 | 3,527 | N/A | 4,940 | N/A |
| 12/31/2014 | 58,089 | 3,393 | N/A | -812 | N/A |
| 9/30/2014 | 57,107 | 3,031 | N/A | 2,013 | N/A |
| 6/30/2014 | 56,517 | 2,972 | N/A | N/A | N/A |
| 3/31/2014 | 58,109 | 3,352 | N/A | -201 | N/A |
| 12/31/2013 | 55,291 | 2,335 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4551's earnings are forecast to decline over the next 3 years (-1% per year).
Earnings vs Market: 4551's earnings are forecast to decline over the next 3 years (-1% per year).
High Growth Earnings: 4551's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 4551's revenue (3.9% per year) is forecast to grow slower than the JP market (4.2% per year).
High Growth Revenue: 4551's revenue (3.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4551's Return on Equity is forecast to be low in 3 years time (4.4%).